Table 2.
Univariate analysis in our cohort.
| Variables | OR | 95% CI | P -value |
|---|---|---|---|
| Systolic blood pressure, / 10 mmHg | 1.19 | 0.97–1.45 | 0.091 |
| Diastolic blood pressure, / 10 mmHg | 1.68 | 1.17–2.40 | 0.005 |
| Heart rate, per min | 1.04 | 1.01–1.07 | 0.007 |
| Smoking (current smokers) | 2.71 | 1.20–6.13 | 0.016 |
| Previous AMI history | 2.82 | 1.01–6.80 | 0.030 |
| ACS | 4.05 | 1.80–9.29 | 0.001 |
| Congestive heart failure (NYHA III-IV) | 6.13 | 0.95–22.18 | 0.017 |
| LVEF, % | 0.94 | 0.90–0.97 | 0.000 |
| LVEF <45 % | 4.13 | 1.18–11.21 | 0.011 |
| LVESD, mm | 1.08 | 1.03–1.12 | 0.001 |
| WBC, × 109 cells per L | 1.22 | 1.02–1.43 | 0.020 |
| NLR | 1.14 | 1.07–1.21 | 0.000 |
| PDW, % | 0.83 | 0.67–1.00 | 0.065 |
| Log (AST), U/L | 3.39 | 1.96–5.57 | 0.000 |
| Baseline UA, μmol/L | 1.00 | 1.00–1.01 | 0.040 |
| TC, mmol/L | 1.28 | 0.93–1.64 | 0.083 |
| LDL, mmol/L | 1.39 | 1.01–1.78 | 0.018 |
| NHDL, mmol/L | 1.29 | 0.93–1.67 | 0.085 |
| Apo B, g/L | 3.62 | 0.84–12.39 | 0.059 |
| CK-MB, U/L | 1.01 | 1.01–1.02 | 0.000 |
| cTnT, ng/mL | 1.49 | 1.19–1.80 | 0.000 |
| Log (NT-proBNP), pg/mL | 2.04 | 1.54–2.74 | 0.000 |
Variables with P < 0.1 are included in the table.
OR, odds ratio; CI, confidence interval; AMI, acute myocardial infarction; ACS, acute coronary syndrome; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic dimension; WBC, white blood cell; NLR, neutrophil to lymphocyte ratio; PDW, platelet distribution width; AST, aspartate aminotransferase; UA, uric acid; TC, total cholesterol; LDL, low-density lipoprotein cholesterol; NHDL, non-high-density lipoprotein cholesterol; Apo B, apolipoprotein B; CK-MB, creatine kinase-MB; cTnT, cardiac troponin T; NT-proBNP, N-terminal pro-brain natriuretic peptide.